Literature DB >> 21795994

Therapy-related noninfectious complications in patients with hematologic malignancies: high-resolution computed tomography findings.

Harald Brodoefel1, Christoph Faul, Helmut Salih, Wolfgang Vogel, Michael Fenchel, Marius Horger.   

Abstract

Pulmonary complications are a leading source of mortality in patients treated for hematologic malignancies. After hematopoietic stem cell transplantation, treatment-related noninfectious complications constitute more than half of the pulmonary pathology and represent a particular diagnostic challenge. This review illustrates the high-resolution computed tomography findings of common therapy-related complications and thereby demonstrates a high degree of overlap between the patterns of various toxicities. Clinical background knowledge of the distinct entities is reviewed and highlighted as an indispensable instrument to narrow the differential diagnosis.

Entities:  

Mesh:

Year:  2013        PMID: 21795994     DOI: 10.1097/RTI.0b013e31822031f0

Source DB:  PubMed          Journal:  J Thorac Imaging        ISSN: 0883-5993            Impact factor:   3.000


  4 in total

1.  CT-guided Core-Needle Biopsy of the Lung Is Safe and More Effective than Fine-Needle Aspiration Biopsy in Patients with Hematologic Malignancies.

Authors:  Gaurav V Watane; Mark M Hammer; Maria F Barile
Journal:  Radiol Cardiothorac Imaging       Date:  2019-12-19

Review 2.  A Systematic Review on Pulmonary Complications Secondary to Hematopoietic Stem Cell Transplantation.

Authors:  Alberto Busmail; Sai Sri Penumetcha; Saher Ahluwalia; Rejja Irfan; Sawleha Arshi Khan; Sai Rohit Reddy; Maria Elisa Vasquez Lopez; Maryam Zahid; Lubna Mohammed
Journal:  Cureus       Date:  2022-05-07

3.  A clinical approach to respiratory disease in patients with hematological malignancy, with a focus on respiratory infection.

Authors:  J Periselneris; J S Brown
Journal:  Med Mycol       Date:  2019-06-01       Impact factor: 4.076

Review 4.  Diagnostic Evaluation of Pulmonary Abnormalities in Patients with Hematologic Malignancies and Hematopoietic Cell Transplantation.

Authors:  Bianca Harris; Alexander I Geyer
Journal:  Clin Chest Med       Date:  2017-06       Impact factor: 2.878

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.